Erythrocyte membrane composition in patients with primary hypercholesterolemia

Clinical Hemorheology and Microcirculation

Volumn 41, Issue 1, 2009, Pages 67-72

  Vaya A ^a,d   Martinez Triguero M ^a   Reganon E ^a   Vila, V ^a   Martinez Sales V ^a   Sola E ^b   Hernandez Mijares A ^b   Ricart, A ^c  

^a La Fe University   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Erythrocyte membrane lipid composition; Primary hypercholesterolemia

Indexed keywords

CHOLESTEROL; HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; FIBRINOGEN; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; ATHEROMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ERYTHROCYTE MEMBRANE; FEMALE; GROUPS BY AGE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LABORATORY TEST; LIPID COMPOSITION; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PRIMARY HYPERCHOLESTEROLEMIA; REPRODUCIBILITY; SEX RATIO; STATISTICAL SIGNIFICANCE; BLOOD; BLOOD GROUP ABO SYSTEM; CASE CONTROL STUDY; ERYTHROCYTE AGGREGATION; HYPERLIPIDEMIA; MIDDLE AGED; PHYSIOLOGY;

ABO BLOOD-GROUP SYSTEM; ADULT; CASE-CONTROL STUDIES; CHOLESTEROL; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 58149396152     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1156     Document Type: Article

References (30)

1. D. Zilberman-Kravits, I. Harman-Boehm, T. Shuster and N. Meyerstein, Increased red cell aggregation is correlated with HbA1C and lipid levels in type 1 but not type 2 diabetes, Clin. Hemorheol. Microcirc. 35 (2006), 463-471.
2. I. Aloulou, E. Varlet-Marie, J. Mercier and J.F. Brun, Hemorheological disturbances correlate with the lipid profile but not with the NCEP-ATPIII score of the metabolic syndrome, Clin. Hemorheol. Microcirc. 35 (2006), 207-212.
3. I. Velcheva, N. Antonova, V. Dimitrova, N. Dimitrov and I. Ivanov, Plasma lipids and blood viscosity in patients with cerebrovascular disease, Clin. Hemorheol. Microcirc. 35 (2006), 155-157.
4. K. Seki, H. Sumino, M. Nara, N. Ishiyama, M. Nishino and M. Murakami, Relationships between blood rheology and age, body mass index, blood cell count, fibrinogen, and lipids in healthy subjects, Clin. Hemorheol. Microcirc. 34 (2006), 401-410.
5. N. Maeda, I. Cicha, N. Tateishi and Y. Suzuki, Triglyceride in plasma: prospective effects on microcirculatory functions, Clin. Hemorheol. Microcirc. 34 (2006), 341-346.
6. A. Vayá, M. Martinez, R. Carmena and J. Aznar, The lipid composition of red blood cells and their hemorheological behavior in patients with primary hyperlipoproteinemia, Clin. Hemorheol. 13 (1993), 447-457.
7. M. Martinez, A. Vayá, R. Martí, L. Gil, I. Lluch, R. Carmena and J. Aznar, Erythrocyte membrane cholesterol/ phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin, Thromb. Res. 83(5) (1996), 375-388.
8. K. Michalska-Malecka, L. Slowinska, M. Dorecka and W. Romaniuk, Correlations in some pathogenetic factors and values of hemorheological parameters in age-related macular degeneration, Clin. Hemorheol. Microcirc. 38(3) (2008), 209-216.
9. M.I. Spengler, S.M. Bertoluzzo, G. Catalani and M.L. Rasia, Study on membrane fluidity and erythrocyte aggregation in equine, bovine and human species, Clin. Hemorheol. Microcirc. 38(3) (2008), 171-176.
10. A. Vaya, M. Martinez, R. Carmena and J. Aznar, Red blood cell aggregation and primary hyperlipoproteinemia, Thromb. Res. 72 (1993), 119-126.
11. M. Martinez, A. Vaya, L. Gil, R. Marti, J. Dalmau and J. Aznar, The cholesterol/phospholipid ratio of the erythrocyte membrane in children with familial hypercholesterolemia. Its relationship with plasma lipids and red blood cell aggregability, Clin. Hemorheol. Microcirc. 18 (1998), 259-263.
12. M. Nikolic, D. Stanic, I. Baricevic, D.R. Jones, O. Nedic and U. Niketic, Efflux of cholesterol and phospholipids derived from the haemoglobin-lipid adduct in human red blood cells into plasma, Clin. Biochem. 40 (2007), 305-309.
13. M. Koter, M. Broncel, J. Chojnowska-Jezierska, K. Kliczynska and I. Franiak, The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia, Eur. J. Clin. Pharmacol. 58 (2002), 501-506.
14. J.F. Duwight, A.C. Mendes-Ribeiro and B.M. Hendry, Effects of HMG-CoA reductase inhibition on erythrocyte membrane cholesterol and acyl chain composition, Clin. Chim. Acta 256 (1996), 53-63.
15. M. Koter, I. Franca, M. Broncel and J. Chojnowska-Jezierska, Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma lipids in patients with type 2 hypercholesterolemia, J. Can. J. Physiol. Pharmacol. 81(5) (2003), 485-492.
16. M. Broncel, A. Bala, M. Koter-Michalak, P. Duchnowicz, W. Wojsznis and J. Chojnowska-Jezierska, Physicochemical modifications induced by statins therapy on human erythrocytes membranes, Wiad. Lek. 60 (7/8) (2007), 321-328.
17. M. Uyuklu, H.J. Meiselman and O.K. Baskurt, Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties, Clin. Hemorheol. Microcirc. 36 (2007), 25-33.
18. E. Arbustini, Total erythrocyte membrane cholesterol, JACC 49(21) (2007), 2090-2092.
19. F.D. Kolodgie, A.P. Burke, G. Nakazawa, Q. Cheng, X. Xu and R. Virmani, Free cholesterol in atherosclerosic plaques: where it come from?, Curr. Opin. Lipidol. 18 (2007), 500-507.
20. P.L. Yeagle, Cholesterol and the cell membrane, Biochem. Biophys. Acta 822 (1985), 267-287.
21. D.N. Tziakas, J.C. Kaski, G.K. Chalikias, C. Romero, S. Fredericks, I.K. Tentes, A.X. Kortsaris, D.I. Hatseras and D.W. Holt, Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome a new marker of clinical instability, JACC 49(21) (2007), 2081-2089.
22. F.D. Kolodgie, K.G. Herman, A.P. Burke et al., Intraplaque hemorrhage and progression of coronary atheroma, N. Engl. J. Med. 349 (2003), 2316-2325.
23. J.T. Dodge, C. Mitchell and D.J. Hanahan, The preparation and chemical characteristics of haemoglobin-free ghosts of human erythrocytes, Arch. Biochem. Biophys. 100 (1963), 119-130.
24. O.H. Lowry, N.J. Rosenproarg and A.L. Farer, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1953), 265-275.
25. A. Vayá, C. Falcó, E. Réganon, V. Vila, V. Martínez-Sales, D. Corella, M.T. Contreras and J. Aznar, Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction, Thromb. Haemost. 91 (2004), 354-359.
26. M. Broncel, M. Balcerak, A. Bala, M. Koper-Michalak, P. Duchnowicz and J. Chojnowska-Jezierska, The erythrocyte membrane structure in patients with mixed hyperlipidemia, Wiad. Lek. 60 (2007), 4-9.
27. R.A. Cooper and J.H. Jandl, Bile salts and cholesterol in the pathogenesis of target cell in obstructive jaundice, J. Clin. Invest. 47 (1968), 809-822.
28. B.P. Schick and P.K. Schick, Cholesterol exchange in platelets, erythrocytes and megakaryocytes, Biochim. Biophys. Acta 833(2) (1985), 281-290.
29. S.I. Muzulu, R.F. Bing and R.I. Norman, Human erythrocyte membrane fluidity and calcium pump activity in primary combined hyperlipidaemia, Clin. Sci. 88 (1985), 307-310.
30. F.D. Kolodgie, A.P. Burke, G. Nakazawa, Q. Cheng, X. Xu and R. Virmani, Free cholesterol in atherosclerotic plaques: where does it come from?, Curr. Opin. Lipidol. 18 (2007), 500-507.